# The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia

> **NCT00846703** · PHASE4 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 600 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** 6-mercaptopurine, Methotrexate
- **DRUG:** 6-mercaptopurine, Methotrexate, Vincristine, Dexamethasone

## Key facts

- **NCT ID:** NCT00846703
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-07
- **Primary completion:** 2013-12
- **Final completion:** 2018-12
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2010-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00846703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00846703, "The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00846703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*